- QMRO Home
- Blizard Institute
- Centre for Immunobiology
- Bridging Fixed Dose to Body Weight-based Regimen of Adalimumab in Paediatric Ulcerative Colitis Using a Pharmacometric Modelling Approach: Case Study with the Phase 3 ENVISION I Trial
Browse
Administrators only